Australia markets closed

Organovo Holdings, Inc. (4OR1.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.6760+0.0080 (+1.20%)
At close: 09:24AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/03/2024
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Total revenue
109
109
370
1,500
0
-
Cost of revenue
-
-
-
-
0
328
Gross profit
-
-
-
-
0
1,868
Operating expenses
Research development
5,498
5,498
8,885
3,320
1,103
-
Selling general and administrative
9,644
9,644
9,088
9,631
15,708
-
Total operating expenses
15,195
15,195
18,101
12,979
16,826
-
Operating income or loss
-15,086
-15,086
-17,731
-11,479
-16,826
-
Total other income/expenses net
12
12
20
25
-13
-
Income before tax
-14,669
-14,669
-17,257
-11,446
-16,824
-
Income tax expense
2
2
2
2
2
-
Income from continuing operations
-14,671
-14,671
-17,259
-11,448
-16,826
-
Net income
-14,671
-14,671
-17,259
-11,448
-16,826
-
Net income available to common shareholders
-14,671
-14,671
-17,259
-11,448
-16,826
-
Basic EPS
-2.15
-1.60
-1.98
-1.32
-2.44
-
Diluted EPS
-2.15
-1.60
-1.98
-1.32
-2.44
-
Basic average shares
8,716
9,145
8,713
8,704
6,902
-
Diluted average shares
8,716
9,145
8,713
8,704
6,902
-